Newscast – Page 146 – media

Maintaining sufficient vitamin D levels may help to prevent rheumatoid arthritis

Maintaining sufficient vitamin D levels may help to prevent the onset of inflammatory diseases like rheumatoid arthritis, research led by the University of Birmingham has discovered.
- Source: medicalxpress
- 583
- November 21, 2017
inflammatory diseases rheumatoid arthritis vitamin D
Bird Flu Is Spreading in Asia, Experts (Quietly) Warn

Since October 2016, China has seen a “fifth wave” of H7N9 infections. Nearly 1,600 people have tested positive, almost 40 percent of whom have died.
- Source: Postnewsreport
- 569
- November 21, 2017
bird flu China H7N9 Researches
High-tech neuroprosthetic ‘Luke’ arm lets amputee touch and feel again

Walgamott was describing the results of an experimental surgery to The Washington Post, where a prosthetic known as the “Luke” arm had been attached with electrodes implanted into his nerves. The real estate agent had lost his hand and most of his arm in an electrical accident 14 years ago, and he volunteered for the program at the University of Utah.
- Source: digitaltrends
- 401
- November 20, 2017
Market Views neuroprosthetic prosthetic
This Artificial Kidney Eliminates The Need For Kidney Dialysis

It is estimated by The National Kidney Foundation that over 100,000 patients are on the waiting list for kidney donors. A further 3,000 names are added to the list every year. An average patient has to wait for 3.6 years for a viable transplant. The patients are treated with dialysis while they are waiting for a transplant and only one in three patients survive for more than five years without a transplant. All that could change as scientists have developed the world’s first artificial kidney.
- Source: wonderfulengineering
- 475
- November 20, 2017
artificial kidney Market Views
Psychedelics and Psychotherapy–Is There a Role for MDMA in the Treatment of PTSD?

In a recent study, scientists investigate the use of MDMA in conjunction with psychotherapy as an aid in treating and alleviating PTSD symptoms.
- Source: medicalnewsbulletin
- 465
- November 20, 2017
psychotherapy PTSD symptom Researches
Cue Biopharma Announces Strategic Research Collaboration and License Agreement with Merck

Biopharma™, Inc., an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat cancer and autoimmune diseases, announced a strategic research collaboration and license agreement with Merck, known as MSD outside of the United States and Canada.
- Source: biotech-365
- 532
- November 20, 2017
autoimmune immunotherapy Market Views
FDA approves new treatment Hemlibra (emicizumab-kxwh) to prevent bleeding in certain patients with hemophilia A

The U.S. Food and Drug Administration(FDA) approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.
- Source: pharmacist
- 744
- November 20, 2017
FDA Hemlibra hemophilia inhibitor New Approvals
Like a baby– The vicious cycle of childhood obesity and snoring

Poor nutrition and lack of exercise lead to the increasing prevalence of obesity which, in turn, is the major predictor of diabetes and future risk of cardiovascular disease in western societies. v
- Source: medicalxpress
- 541
- November 20, 2017
cardiovascular disease diabetes obesity obstructive sleep apnea
Clinical trial shows treatment is ‘transformative’ for babies with spinal muscular atrophy

Infants with the most severe form of spinal muscular atrophy (SMA) were more likely to show gains in motor function and were 47 percent more likely to survive without permanent assisted ventilation support when treated with a new medication, according to a study published today in the New England Journal of Medicine. The drug, nusinersen, performed so well that the study was stopped early and the treatment was approved shortly thereafter by the U.S. Food and Drug Administration (FDA) for all patients with this progressive neuromuscular disorder.
- Source: sciencedaily
- 453
- November 17, 2017
Market Views neuromuscular disorder SMA
Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation

Celgene Corporation and bluebird bio, Inc. announced that bb2121, a chimeric antigen receptor T-cell (CAR-T) therapy targeting b-cell maturation antigen (BCMA) in previously treated patients with multiple myeloma, has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) and PRIority MEdicines (PRIME) eligibility by the European Medicines Agency (EMA).
- Source: ansa.it
- 590
- November 17, 2017
BTD CAR-T therapy Company Insight

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.